http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111939166-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-185
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00
filingDate 2020-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2022-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-111939166-B
titleOfInvention Application of aescin in preparing medicine for treating ulcerative colitis
abstract The invention discloses an application of aescin in preparing a medicine for treating ulcerative colitis. Aescin obtained from Chinese medicine buckeye seed has the functions of clearing heat, arresting bleeding, diminishing inflammation, eliminating blood stasis and the like, and has obvious preventing and treating functions on symptoms such as abdominal pain, diarrhea, mucopurulent bloody stool and the like caused by ulcerative colitis.
priorityDate 2020-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009118204-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496112
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10680
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408196011
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5339
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11146
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21661957
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419477430
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410443927
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6476031
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426113427
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426079160
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433321677
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702

Total number of triples: 29.